17 December 2007
Cardiopulmonary bypass in a pregnant woman complicated with infective endocarditis: a case report
Iclal Ozdemir Kol, Gonca Imir, Kenan Kaygusuz, Sinasi Manduz, Sinan Gursoy, Mustafa GonulluCase Rep Clin Pract Rev 2007; 8:357-359 :: ID: 628121
Abstract
Background: Infective endocarditis is a rare but life-threatening complication of pregnancy. The fi rst choice of treatment of patients with infective endocarditis should be medical in pregnant woman; however, in cases that are not responsive to medical treatment, corrective cardiac operations are inevitable.
Case Report: This report presents a successfully managed unusual case of cardiopulmonary bypass in a pregnant woman complicated by the infective endocarditis.
Conclusions: Early diagnosis, immediate intervention and the continuous fetal cardiotocography help to reduce fetal complications during the cardiopulmonary bypass. In the pregnant women with infective endocarditis underwent cardiopulmonary bypass, it should be kept in mind to avoid agents which induces uterine contractions as inotropics, to supply adequate uterine blood fl ow by high flow-high pressure perfusion, and appropriate monitorization of the mother and the fetus. In the management of these very high powered risk cases, a successful outcome can be achieved with a multidisciplinary approach.
Keywords: infective endocarditis, Cardiopulmonary Bypass, pregnant woman
407
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945747
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945539
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945795
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946588
Most Viewed Current Articles
21 Jun 2024 : Case report
88,518
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
50,005
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
25,154
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
22,640
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030